Earth Science Tech, Inc. Stock Other OTC
Equities
ETST
US2703111037
Pharmaceuticals
Financials (USD)
Sales 2022 | 14.12K | Sales 2023 | 48.54K | Capitalization | 9.24M |
---|---|---|---|---|---|
Net income 2022 | 3M | Net income 2023 | - | EV / Sales 2022 | 103 x |
Net Debt 2022 | 656K | Net Debt 2023 | 1.06M | EV / Sales 2023 | 212 x |
P/E ratio 2022 |
0.25
x | P/E ratio 2023 |
-13.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.95% |
Managers | Title | Age | Since |
---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 22-09-30 |
Mario Tabraue
COO | Chief Operating Officer | 45 | 21-10-31 |
Sergio Castillo
SAM | Sales & Marketing | 40 | 17-01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Tabraue
COO | Chief Operating Officer | 45 | 21-10-31 |
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 22-09-30 |
Yovan Sanchez
BRD | Director/Board Member | 43 | Nov. 06 |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |